These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16962380)

  • 1. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
    Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
    Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
    Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K
    Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
    Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
    Bourgeois BF; D'Souza J
    Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
    Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
    Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine in infants and young children with partial seizures.
    Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
    Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
    Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
    Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
    Beydoun A; Sachdeo RC; Kutluay E; McCague K; D'Souza J
    Epilepsia; 2003 Sep; 44(9):1160-5. PubMed ID: 12919387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M; Krause E; Kuhn K; Peper R; Vogel H
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
    Albani F; Grassi B; Ferrara R; Turrini R; Baruzzi A;
    Seizure; 2004 Jun; 13(4):254-63. PubMed ID: 15121136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
    Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
    Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.